Entertainment Legal News

CPSC, MGA Entertainment Inc. Announce Recall

WASHINGTON, D.C. – The U.S. Consumer Product Safety Commission, in cooperation with the manufacturer named below, today announced voluntary recall of the following consumer product. Consumers should stop using recalled product immediately unless otherwise instructed.

Name of Product: Bratz™ Stylin’ Scooter™

Units: About 297,000

Distributor: MGA Entertainment Inc., of Van Nuys, Calif.

Manufacturer: Jurong Dumar Bicycle, Inc. of China. This recall does not include Bratz™ Stylin’ Scooters™ manufactured for MGA by any manufacturer other than Jurong Dumar Bicycle, Inc.

Hazard: The wheels of the scooter can break or become damaged, and users of the scooters can fall and suffer injuries.

Incidents/Injuries: MGA has received six reports of cracked wheels on the recalled scooters. All six incidents resulted in cuts, scrapes, and bruises. In one case, a 9 year old suffered a broken arm.

Description: The product is a non-motorized two-wheeled scooter with a folding hinge and an adjustable handlebar. The scooter platform is purple with a bright pink Bratz logo on the top surface. Scooters containing information identifying the product as Item No. 266563, with a date of manufacture prior to July 2004, and manufactured by Jurong Dumar Bicycle, Inc. are included in this recall. This identification information can be located either in the area directly beneath the scooter platform or at the bottom of the scooter near the rear wheel.

Sold at: Toy and discount chain stores nationwide from September 2003 through November 2004 for about $30.

Manufactured in: China.

Remedy: Consumers should stop using the scooter immediately and contact MGA for a refund or a replacement scooter.

Consumer Contact: For additional information, contact MGA toll-free at (800) 222-4685 anytime or visit the company’s Web site at mgae.com.

Contact our Missouri Entertainment Lawyers now and obtain a free case review!

	Did You Know?
	Treatment is one of the starting blocks in the development process The treatment takes the outline a step further, adding depth to character and story by filling in missing blanks. The treatment's main purpose is to tell the complete story before setting it in script form. Most are written in prose and range from ten to twenty pages. The treatment is the best place to hammer out initial story and character problems. Unless a script is sold on spec, most buyers require a treatment (or very detailed) outline from its writers before commencement of the actual screenplay. If financed independently, the treatment's often a part of the initial fundraising package.